Rehmann Capital Advisory Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Buy |
|
|||||
|
2025
Q1 | $248K | Buy |
|
|||||
|
2024
Q4 | $207K | Buy |
|
|||||
|
2024
Q3 | $232K | Buy |
|
|||||
|
2024
Q2 | $203K | Buy |
|
|||||
|
2024
Q1 | $212K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $217K | Buy |
|
|||||
|
2019
Q3 | $186K | Sell |
|
|||||
|
2019
Q2 | $179K | Buy |
|
|||||
|
2019
Q1 | $170K | Buy |
|
|||||
|
2018
Q4 | $106K | Buy |
|
|||||
|
2018
Q3 | $104K | Sell |
|
|||||
|
2018
Q2 | $115K | Sell |
|
|||||
|
2018
Q1 | $171K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $264K | Sell |
|
|||||
|
2017
Q2 | $308K | Sell |
|
|||||
|
2017
Q1 | $349K | Sell |
|
|||||
|
2016
Q4 | $329K | Sell |
|
|||||
|
2016
Q3 | $389K | Sell |
|
|||||
|
2016
Q2 | $398K | Buy |
|
|||||
|
2016
Q1 | $363K | Sell |
|
|||||
|
2015
Q4 | $393K | Buy |
|
|||||
|
2015
Q3 | $346K | Buy |
|
|||||
|
2015
Q2 | $270K | Sell |
|
|||||
|
2015
Q1 | $303K | Sell |
|
|||||
|
2014
Q4 | $285K | Sell |
|
|||||
|
2014
Q3 | $344K | Buy |
|
|||||
|
2014
Q2 | $393K | Buy |
|
|||||
|
2014
Q1 | $384K | Sell |
|
|||||
|
2013
Q4 | $391K | Buy |
|
|||||
|
2013
Q3 | $346K | Buy |
|
|||||
|
2013
Q2 | $334K | Buy |
|